Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | fructose-1,6-bisphosphatase | 0.1055 | 1 | 1 |
Leishmania major | 0.1055 | 1 | 1 | |
Trypanosoma brucei | sedoheptulose-1,7-bisphosphatase | 0.0392 | 0.3631 | 0.3631 |
Loa Loa (eye worm) | fructose-1,6-bisphosphatase | 0.1055 | 1 | 1 |
Echinococcus multilocularis | fructose 1,6 bisphosphatase 1 | 0.1055 | 1 | 0.5 |
Toxoplasma gondii | fructose-bisphospatase II | 0.1055 | 1 | 1 |
Trypanosoma cruzi | sedoheptulose-1,7-bisphosphatase, putative | 0.0392 | 0.3631 | 0.3631 |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.1055 | 1 | 1 |
Schistosoma mansoni | fructose-16-bisphosphatase-related | 0.1055 | 1 | 0.5 |
Trypanosoma cruzi | sedoheptulose-1,7-bisphosphatase, putative | 0.0392 | 0.3631 | 0.3631 |
Trypanosoma cruzi | fructose-1,6-bisphosphatase, cytosolic, putative | 0.1055 | 1 | 1 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0015 | 0 | 0.5 |
Echinococcus granulosus | fructose 16 bisphosphatase 1 | 0.1055 | 1 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.